Pacific Biosciences Of California (PACB) FCF Margin (2010 - 2026)

Pacific Biosciences Of California has reported FCF Margin for 17 years, with the latest figure at 95.21% in Q2 2026.

• On a quarterly basis, FCF Margin fell 1995.0% year-over-year to 95.21% in Q2 2026; TTM through Jun 2026 was 77.49%, a 2008.0% increase from a year earlier, with the FY2025 full-year figure at 71.2%, up 6661.0% from the prior year.
• FCF Margin was 95.21% for Q2 2026 at Pacific Biosciences Of California, up from 128.39% in the prior quarter.
• The five-year high for FCF Margin was 44.64% in Q4 2025, with the low at 252.99% in Q1 2023.
• Average FCF Margin over 5 years is 139.61%, with a median of 120.42% recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: FCF Margin tumbled 16814 bps in 2022, then soared 13725 bps in 2023.
• Over 5 years, FCF Margin stood at 239.35% in 2022, then soared by 57 bps to 102.1% in 2023, then rose by 19 bps to 82.26% in 2024, then surged by 46 bps to 44.64% in 2025, then slumped by 113 bps to 95.21% in 2026.
• The last three FCF Margin figures came in at 95.21% (Q2 2026), 128.39% (Q1 2026), and 44.64% (Q4 2025), per Business Quant data.